Literature DB >> 8424464

Centrocytic lymphoma: a morphometric study with comparison to other small cleaved follicular center cell lymphomas and genotypic correlates.

S H Swerdlow1, M H Saboorian, R J Pelstring, M E Williams.   

Abstract

Centrocytic lymphoma (ML,CC) is distinguished from other cleaved follicular center cell (FCC) lymphomas in the Kiel classification by the lack of noncleaved FCC and not by morphological differences between the centrocytes (cleaved cells). Immunophenotypic and genotypic studies, however, have shown that the centrocytes in ML,CC are distinct from those of other small cleaved FCC lymphomas (ML,FCC,SC). To morphologically compare the cells of ML,CC with nine previously studied ML,FCC,SC and to relate the findings in ML,CC to the varied descriptions of lymphomas of intermediate differentiation, a morphometric analysis of 22 ML,CC was performed. Nuclei in ML,CC were, on average, significantly larger, rounder, and had less frequent nucleoli than those in ML,FCC,SC; however, the proportion of small round lymphocytes did not differ. Among the ML,CC, the only apparent immunophenotypic/genotypic correlate that was identified was greater nuclear ellipticity for the biopsies lacking chromosome 11q13 bcl-1 or PRAD1 rearrangement. Repeat biopsies in four patients with ML,CC showed an increase in nuclear size. These data demonstrate that a lack of transformed cells is not the only morphological difference between ML,CC and ML,FCC,SC. The morphological distinction, however, is not based on the proportion of small round lymphocytes present. In addition, the morphometric parameters illustrate the nuclear variability among ML,CC and demonstrate how the disease may evolve over time.

Entities:  

Mesh:

Year:  1993        PMID: 8424464      PMCID: PMC1886829     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.

Authors:  M E Williams; T C Meeker; S H Swerdlow
Journal:  Blood       Date:  1991-07-15       Impact factor: 22.113

2.  Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations.

Authors:  P Lardelli; M A Bookman; J Sundeen; D L Longo; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1990-08       Impact factor: 6.394

3.  Morphometric analysis of follicular center cells: a new approach.

Authors:  R J Pelstring; S H Swerdlow
Journal:  Mod Pathol       Date:  1988-07       Impact factor: 7.842

4.  Improved nuclear contour indices for lymphoid morphometry.

Authors:  R J Pelstring; S H Swerdlow
Journal:  Anal Quant Cytol Histol       Date:  1987-12       Impact factor: 0.302

5.  Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma.

Authors:  D A Perry; M A Bast; J O Armitage; D D Weisenburger
Journal:  Cancer       Date:  1990-11-01       Impact factor: 6.860

6.  Morphometric analysis of follicular center cell lymphomas.

Authors:  S H Swerdlow; R J Pelstring; R D Collins
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

7.  Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.

Authors:  L J Medeiros; J H Van Krieken; E S Jaffe; M Raffeld
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

8.  Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus.

Authors:  M E Williams; C D Westermann; S H Swerdlow
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

9.  Determination of transferrin receptors on frozen sections of malignant B-cell lymphomas by immunofluorescence with a monoclonal antibody.

Authors:  P B Oudemans; G Brutel de la Rivière; G A Hart; P van Heerde; G Scholte; T M Vroom
Journal:  Cancer       Date:  1986-09-15       Impact factor: 6.860

10.  Neoplastic and reactive follicles within B-cell malignant lymphomas. A morphological and immunological study of 30 cases.

Authors:  S Pileri; M T Rivano; M Gobbi; D Taruscio; K Lennert
Journal:  Hematol Oncol       Date:  1985 Oct-Dec       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.